Point-spectroscopy Trial

Spectroscopic Assessment of Autofluorescent Signatures of Tissue in and Around Wounds Identified by MolecuLightDX Imaging Device

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05183698

Enrollment

Registered

2022-01-11

Start date

2022-02-24

Completion date

2022-12-01

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound, Wound of Skin

Brief summary

Evaluation and characterization of autofluorescence signals of tissue in and around wounds as identified by MolecuLight fluorescence image.

Detailed description

Evaluate and characterize autofluorescence signals of tissue components in and around wounds identified by MolecuLight FL images using a point spectrometer. The fluorescence spectroscopy data will yield quantitative spectral information, including the relative intensity and emission peak of the biological autofluorescence signatures.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Patients presenting with acute or chronic wounds * 18 years or older * Willing to consent

Exclusion criteria

* Treatment with an investigational drug within 1 month of enrolment * Any contra-indication to regular wound care * Inability or unwillingness to consent

Design outcomes

Primary

Measure	Time frame	Description
Spectra of autofluorescent signatures of tissue in and around the wounds	2 months	Spectral characterization (i.e. emission curve including intensity) of the autofluorescence signal from wound tissue and surrounding tissue will be catalogued from all 50 study participants.

Countries

Canada

Outcome results